Efficacy and Safety of aerosolizedDornase Alfa Administration in Patients With COVID19 Induced ARDS (COVIDORNASE)

NCT04355364 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

77

Enrollment

NETWORK

Sponsor class

Stopped No signal of benefit of treatment.

Conditions

COVID-19
Acute Respiratory Distress Syndrome

Interventions

DRUG: Dornase Alfa Inhalation Solution [Pulmozyme]
PROCEDURE: standard procedure

Sponsor

Fondation Ophtalmologique Adolphe de Rothschild

Collaborators

[object Object]
[object Object]